CLEVELAND, Dec. 4, 2008 (GLOBE NEWSWIRE) -- Athersys, Inc. (NasdaqCM:ATHX - News) today announced it will participate at the RBC Capital Markets 2008 Healthcare Conference, to be held December 10-11, 2008, at the Westin Times Square hotel in New York City.
Gil Van Bokkelen, Chairman and Chief Executive of Athersys, will participate on a panel entitled ``Shrinking the Obesity Epidemic’’ on Wednesday, December 10th, at 11:00 AM (Eastern Time). Investors may listen to a live audio webcast of the panel moderated by RBC’s Ken Trobovich by accessing the following link: http://www.wsw.com/webcast/rbc95/panel6/.
A webcast replay of the presentation can be accessed via the company’s web site at: http://www.athersys.com, under the Investors section.
About Athersys, Inc.
Athersys is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. In addition to its lead product candidate, ATHX-105, the Company is developing other orally active pharmaceutical product candidates for the treatment of metabolic and central nervous system disorders. Athersys is also developing MultiStem(r), a patented, adult-derived ``off-the-shelf’’ stem cell product platform for multiple disease indications, including damage caused by myocardial infarction, bone marrow transplantation/oncology support, ischemic stroke and other indications. More information is available at http://www.athersys.com.
The Athersys, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4548
Contact:
Athersys, Inc. William (B.J.) Lehmann, J.D., President and Chief Operating Officer (216) 431-9900 bjlehmann@athersys.com
In-Site Communications Lisa M. Wilson (917) 543-9932 lwilson@insitecony.com
Source: Athersys, Inc.
